Intended for healthcare professionals


Patients' views on cost effectiveness of drugs are important

BMJ 2000; 321 doi: (Published 18 November 2000) Cite this as: BMJ 2000;321:1292
  1. Kristian Pollock (, concordance research fellow,
  2. Janet Grime, concordance research fellow
  1. Department of Medicines Management, Keele University, Keele, Staffordshire ST5 5BG

    EDITOR—The report by the National Institute for Clinical Excellence on the use of proton pump inhibitors for treating dyspepsia sets the target of at least a 15% reduction in prescribing of these drugs in England and Wales, with consequent savings of £40m-£50m a year.1

    We carried out a qualitative study of patients' and general practitioners' views of long term use of proton pump inhibitors. Patients commonly expressed concerns about long term use of the drugs but said that they …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription